Back to Trades
Buy4
Mobia Medical, Inc.
MOBI
Total Value
$8.5M
Net $8.0M bought
Purchases
$8.0M
2 transactions
Company Information
- Company Name
- Mobia Medical, Inc.
- Ticker Symbol
- MOBI
- CIK
- 0001489993
Insider Information
- Role
- Director, 10% Owner
- Location
- AUSTIN, TX
Director10% Owner
Filing Details
- Filing Date
- May 11, 2026
- Transaction Date
- Jan 30, 2026
- Accession Number
- 0001628280-26-033811
- Form Type
- 4
- Net Trading Amount
- $8.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | 284,324 | — | C | — |
| May 11, 2026 | Common Stock | 264,746 | — | C | — |
| May 11, 2026 | Common Stock | 1,455,726 | — | C | — |
| May 11, 2026 | Common Stock | 872,770 | — | C | — |
| May 11, 2026 | Common Stock | 266,666 | $15.00 | Purchase | $4.0M |
| May 11, 2026 | Common Stock | 266,667 | $15.00 | Purchase | $4.0M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| — | Derivative | 3,411,892.25 | — | Grant/Award | — |
| — | Derivative | 3,176,955.03 | — | Grant/Award | — |
| May 7, 2026 | Derivative | 31,520 | $15.00 | Grant/Award | $472.8K |
| May 11, 2026 | Derivative | 3,411,892.25 | — | C | — |
| May 11, 2026 | Derivative | 3,176,955.03 | — | C | — |
| May 11, 2026 | Derivative | 3,930,352 | — | C | — |
| May 11, 2026 | Derivative | 1,139,946 | — | C | — |
| May 11, 2026 | Derivative | 3,039,860 | — | C | — |
Footnotes
- (F1)The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.
- (F2)The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any.
- (F3)The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any.
- (F4)Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms.
- (F5)This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).
- (F6)The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.